Company filings profile · CIK 0001834105

IMPACT BIOMEDICAL INC. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for IMPACT BIOMEDICAL INC. (IBO): 7 filings in the last 90 days vs 3 in the prior 90 (filing-velocity rising ↑ · 2.33×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Oct 10, 2026. Source-linked, daily-refreshed.

Material 8-K events — IMPACT BIOMEDICAL INC.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Oct 9, 2026Amendments to Bylaws/Charter; Financial Statements and Exhibits↗
Sep 17, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Sep 15, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Mar 4, 2026Entry into a Material Agreement; Financial Statements and Exhibits↗
Nov 6, 2025Item 5.07↗
Oct 27, 2025Other Events↗
Jul 28, 2025Entry into a Material Agreement; Financial Statements and Exhibits↗
Jun 23, 2025Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits↗
Apr 3, 2025Entry into a Material Agreement↗

Watch IMPACT BIOMEDICAL INC. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Sep 24, 20264↗
Mar 30, 20264↗
Mar 25, 20264↗
Jan 6, 20264↗
May 27, 20254↗
Apr 7, 20254↗
Apr 7, 20254↗
Apr 4, 20254↗
Apr 2, 20254↗
Mar 28, 20254↗
Mar 24, 20254↗
Dec 9, 20244↗
Dec 3, 20244↗
Dec 3, 20244↗
Nov 22, 20244↗
Sep 19, 20244↗
Sep 18, 20244↗

Recent filings

FiledFormDetail
Oct 9, 20268-K Amendments to Bylaws/Charter; Financial Statements and Exhibits ↗
Sep 24, 20264 4 ↗
Sep 17, 2026425 425 ↗
Sep 17, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Sep 15, 2026425 425 ↗
Sep 15, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Aug 7, 202610-Q 10-Q ↗
May 12, 202610-Q 10-Q ↗
Apr 29, 2026144 ↗
Apr 22, 2026S-8 POS S-8 POS ↗
Apr 6, 2026S-8 POS S-8 POS ↗
Mar 30, 20264 4 ↗
Mar 25, 20264 4 ↗
Mar 11, 202610-K 10-K ↗
Mar 4, 20268-K Entry into a Material Agreement; Financial Statements and Exhibits ↗
Jan 6, 20264 4 ↗
Dec 30, 2025DEF 14C DEF 14C ↗
Dec 11, 2025PRE 14C PRE 14C ↗
Nov 7, 202510-Q 10-Q ↗
Nov 6, 20258-K Item 5.07 ↗
Oct 27, 20258-K Other Events ↗
Sep 22, 2025DEF 14A DEF 14A ↗
Sep 9, 2025DEF 14C DEF 14C ↗
Aug 25, 2025PRE 14C PRE 14C ↗
Aug 14, 202510-Q 10-Q ↗
Aug 5, 2025DEF 14C DEF 14C ↗
Jul 28, 20258-K Entry into a Material Agreement; Financial Statements and Exhibits ↗
Jul 16, 2025PRE 14C PRE 14C ↗
Jun 23, 20258-K Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits ↗
May 27, 20254 ↗
May 14, 202510-Q 10-Q ↗
Apr 7, 20254 ↗
Apr 7, 20254 ↗
Apr 4, 20254 ↗
Apr 4, 2025SCHEDULE 13D/A ↗
Apr 3, 20258-K Entry into a Material Agreement ↗
Apr 2, 2025SCHEDULE 13D ↗
Apr 2, 20254 ↗
Mar 28, 20254 ↗
Mar 28, 202510-K ↗